Cardiac involvement in adults with Pompe disease

Journal of Internal Medicine

Volumn 264, Issue 4, 2008, Pages 333-339

  Soliman, O I I ^a   Van Der Beek, N A M E ^a   Van Doorn, P A ^a   Vletter, W B ^a   Nemes, A ^a   Van Dalen, B M ^a   Ten Cate, F J ^a   Van Der Ploeg, A T ^a   Geleijnse, M L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cardiomyopathy; Echocardiography; Glycogen storage disease

Indexed keywords

ALPHA GLUCOSIDASE; DOBUTAMINE; FUROSEMIDE; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; ASSISTED VENTILATION; CLINICAL ARTICLE; CLINICAL EXAMINATION; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; EDEMA; ELECTROCARDIOGRAPHY; EXERCISE TOLERANCE; FEMALE; FLUID RETENTION; GLYCOGEN STORAGE DISEASE TYPE 2; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART LEFT ANTERIOR BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONTRACTILITY; HEART RIGHT BUNDLE BRANCH BLOCK; HEART RIGHT VENTRICLE HYPERTROPHY; HIS BUNDLE; HUMAN; HYPERTENSION; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY; WALKING AID; WHEELCHAIR;

ADULT; AGED; CASE-CONTROL STUDIES; DOBUTAMINE; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER, PULSED; EXERCISE TOLERANCE; FEMALE; GLYCOGEN STORAGE DISEASE TYPE II; HEART DISEASES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 51749083302     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2008.01966.x     Document Type: Article

References (31)

1. Hers HG. alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe's disease). Biochem J 1963 86: 11 6.
2. Ausems MG, Verbiest J, Hermans MP et al. Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling. Eur J Hum Genet 1999 7: 713 6.
3. Martiniuk F, Chen A, Mack A et al. Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease. Am J Med Genet 1998 79: 69 72.
4. Raben N, Plotz P, Byrne BJ. Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease). Curr Mol Med 2002 2: 145 66.
5. Arad M, Maron BJ, Gorham JM et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 2005 352: 362 72.
6. Hagemans ML, Winkel LP, Hop WC, Reuser AJ, Van Doorn PA, Van der Ploeg AT. Disease severity in children and adults with Pompe disease related to age and disease duration. Neurology 2005 64: 2139 41.
7. Winkel LP, Hagemans ML, van Doorn PA et al. The natural course of non-classic Pompe's disease; a review of 225 published cases. J Neurol 2005 252: 875 84.
8. Senior R, Andersson O, Caidahl K et al. Enhanced left ventricular endocardial border delineation with an intravenous injection of SonoVue, a new echocardiographic contrast agent: a European multicenter study. Echocardiography 2000 17: 705 11.
9. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989 2: 358 67.
10. Devereux RB, Alonso DR, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986 57: 450 8.
11. Khouri SJ, Maly GT, Suh DD, Walsh TE. A practical approach to the echocardiographic evaluation of diastolic function. J Am Soc Echocardiogr 2004 17: 290 7.
12. Nikitin NP, Witte KK, Thackray SD, de Silva R, Clark AL, Cleland JG. Longitudinal ventricular function: normal values of atrioventricular annular and myocardial velocities measured with quantitative two-dimensional color Doppler tissue imaging. J Am Soc Echocardiogr 2003 16: 906 21.
13. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997 30: 1527 33.
14. Ommen SR, Nishimura RA, Appleton CP et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler- catheterization study. Circulation 2000 102: 1788 94.
15. Geleijnse ML, Fioretti PM, Roelandt JR. Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol 1997 30: 595 606.
16. Kroos MA, Pomponio RJ, Hagemans ML et al. Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype. Neurology 2007 68: 110 5.
17. Kishnani PS, Hwu WL, Mandel H, Nicolino M, Yong F, Corzo D. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr 2006 148: 671 6.
18. Ansong AK, Li JS, Nozik-Grayck E et al. Electrocardiographic response to enzyme replacement therapy for Pompe disease. Genet Med 2006 8: 297 301.
19. Bulkley BH, Hutchins GM. Pompe's disease presenting as hypertrophic myocardiopathy with Wolff-Parkinson-White syndrome. Am Heart J 1978 96: 246 52.
20. Arad M, Moskowitz IP, Patel VV et al. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation 2003 107: 2850 6.
21. Munger TM, Packer DL, Hammill SC et al. A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989. Circulation 1993 87: 866 73.
22. Fuster V, Ryden LE, Cannom DS et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006 8: 651 745.
23. Kreger BE, Anderson KM, Kannel WB. Prevalence of intraventricular block in the general population: the Framingham Study. Am Heart J 1989 117: 903 10.
24. Poulsen SH, Andersen NH, Ivarsen PI, Mogensen CE, Egeblad H. Doppler tissue imaging reveals systolic dysfunction in patients with hypertension and apparent "isolated" diastolic dysfunction. J Am Soc Echocardiogr 2003 16: 724 31.
25. Munagala VK, Jacobsen SJ, Mahoney DW, Rodeheffer RJ, Bailey KR, Redfield MM. Association of newer diastolic function parameters with age in healthy subjects: a population-based study. J Am Soc Echocardiogr 2003 16: 1049 56.
26. Ausems MG, Lochman P, van Diggelen OP, Ploos van Amstel HK, Reuser AJ, Wokke JH. A diagnostic protocol for adult-onset glycogen storage disease type II. Neurology 1999 52: 851 3.
27. Kroos MA, Van der Kraan M, Van Diggelen OP et al. Glycogen storage disease type II: frequency of three common mutant alleles and their associated clinical phenotypes studied in 121 patients. J Med Genet 1995 32: 836 7.
28. Seifert BL, Snyder MS, Klein AA, O'Loughlin JE, Magid MS, Engle MA. Development of obstruction to ventricular outflow and impairment of inflow in glycogen storage disease of the heart: serial echocardiographic studies from birth to death at 6 months. Am Heart J 1992 123: 239 42.
29. van den Hout HM, Hop W, van Diggelen OP et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics 2003 112: 332 40.
30. Reuser AJ, Kroos MA, Hermans MM et al. Glycogenosis type II (acid maltase deficiency). Muscle Nerve 1995 3: S61 9.
31. Merin RG. Myocardial metabolism for the toxicologist. Environ Health Perspect 1978 26: 169 74.